{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T05:55:23Z","timestamp":1785477323539,"version":"3.56.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jaci-inpractice.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jaip.2023.06.038","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T17:53:53Z","timestamp":1687974833000},"page":"3040-3046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Food Immunotherapy: Dissecting Current Guidelines and Navigating the Gray Zone"],"prefix":"10.1016","volume":"11","author":[{"given":"Aikaterini","family":"Anagnostou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Rodr\u00edguez del R\u00edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2023.06.038_bib1","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1542\/peds.2011-0204","article-title":"The prevalence, severity, and distribution of childhood food allergy in the United States","volume":"128","author":"Gupta","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2023.06.038_bib2","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-1235","article-title":"The public health impact of parent-reported childhood food allergies in the United States","volume":"142","author":"Gupta","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2023.06.038_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.5630","article-title":"Prevalence and severity of food allergies among US adults","volume":"2","author":"Gupta","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaip.2023.06.038_bib4","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1046\/j.1365-2222.2000.00889.x","article-title":"The psychological burden of peanut allergy as perceived by adults with peanut allergy and the parents of peanut-allergic children","volume":"30","author":"Primeau","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2023.06.038_bib5","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1111\/all.14363","article-title":"APPEAL-1: a multiple-country European survey assessing the psychosocial impact of peanut allergy","volume":"75","author":"DunnGalvin","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.06.038_bib6","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1542\/peds.2011-1762","article-title":"Allergic reactions to foods in preschool-aged children in a prospective observational food allergy study","volume":"130","author":"Fleischer","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2023.06.038_bib7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.anai.2020.01.008","article-title":"Food reactions during avoidance: focus on peanut","volume":"124","author":"Capucilli","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.06.038_bib8","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.jaip.2020.12.018","article-title":"Characteristics of food allergic reactions in United States restaurants","volume":"9","author":"Oriel","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.06.038_bib9","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jaci.2017.09.012","article-title":"Self-reported adverse food reactions and anaphylaxis in the SchoolNuts study: a population-based study of adolescents","volume":"141","author":"McWilliam","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.06.038_bib10","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa1812856","article-title":"AR101 oral immunotherapy for peanut allergy","volume":"379","author":"Vickery","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.06.038_bib11","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.jaci.2021.12.780","article-title":"Safety of peanut (Arachis hypogaea) allergen powder-dnfp in children and teenagers with peanut allergy: pooled summary of phase 3 and extension trials","volume":"149","author":"Brown","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.06.038_bib12","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0140-6736(13)62301-6","article-title":"Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial","volume":"383","author":"Anagnostou","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2023.06.038_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaci.2016.05.027","article-title":"Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective","volume":"139","author":"Vickery","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.06.038_bib14","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jaip.2020.07.009","article-title":"Five-year follow-up of early intervention peanut oral immunotherapy","volume":"9","author":"Herlihy","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.06.038_bib15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1200435","article-title":"Oral immunotherapy for treatment of egg allergy in children","volume":"367","author":"Burks","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.06.038_bib16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(21)02390-4","article-title":"Efficacy and safety of oral immunotherapy in children aged 1\u20133 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study","volume":"399","author":"Jones","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2023.06.038_bib17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/pai.12869","article-title":"Safety and efficacy of epicutaneous immunotherapy for food allergy","volume":"29","author":"Wang","year":"2018","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2023.06.038_bib18","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaip.2017.10.023","article-title":"Current status and unanswered questions for food allergy treatments","volume":"6","author":"Rachid","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.06.038_bib19","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1016\/j.jaip.2020.03.043","article-title":"Peanut oral immunotherapy protects patients from accidental allergic reactions to peanut","volume":"8","author":"Trendelenburg","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.06.038_bib20","doi-asserted-by":"crossref","first-page":"S777","DOI":"10.1016\/j.jaci.2008.12.266","article-title":"Threshold dose for peanut allergy during peanut oral immunotherapy procedure in children","volume":"123","author":"Christie","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.06.038_bib21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jaip.2017.05.006","article-title":"Quantitative assessment of the safety benefits associated with increasing clinical peanut thresholds through immunotherapy","volume":"6","author":"Baumert","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.jaip.2023.06.038_bib22","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.anai.2019.08.007","article-title":"Estimated risk reduction to packaged food reactions by epicutaneous immunotherapy (EPIT) for peanut allergy","volume":"123","author":"Remington","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.06.038_bib23","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/039463201202500329","article-title":"Impact of oral immunotherapy on quality of life in children with cow milk allergy: a pilot study","volume":"25","author":"Carraro","year":"2012","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.jaip.2023.06.038_bib24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jaip.2018.06.016","article-title":"Quality of life of food-allergic patients before, during, and after oral immunotherapy","volume":"7","author":"Epstein-Rigbi","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.06.038_bib25","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1016\/j.jaip.2020.04.021","article-title":"Dosing, safety, and quality of life after peanut immunotherapy trials: a long-term follow-up study","volume":"8","author":"Cook","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.06.038_bib26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1710-1492-10-57","article-title":"Two year effects of food allergen immunotherapy on quality of life in caregivers of children with food allergies","volume":"10","author":"Arasi","year":"2014","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2023.06.038_bib27","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/MOP.0000000000000684","article-title":"Food immunotherapy for children with food allergies: state of the art and science","volume":"30","author":"Anagnostou","year":"2018","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.jaip.2023.06.038_bib28","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2010.10.008","article-title":"Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel","volume":"126","author":"Boyce","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.06.038_bib29","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jaci.2014.05.013","article-title":"Food allergy: a practice parameter update\u20142014","volume":"134","author":"Sampson","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.06.038_bib30","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.jaip.2021.02.046","article-title":"An approach to the office-based practice of food oral immunotherapy","volume":"9","author":"Wasserman","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.06.038_bib31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2147\/JAA.S290915","article-title":"A\u00a0practical, stepwise approach to peanut oral immunotherapy in clinical practice: benefits and risks","volume":"14","author":"Anagnostou","year":"2021","journal-title":"J\u00a0Asthma Allergy"},{"key":"10.1016\/j.jaip.2023.06.038_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2020.11.011","article-title":"Integrating oral immunotherapy into clinical practice","volume":"147","author":"Leonard","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.06.038_bib33","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jaci.2020.05.027","article-title":"Consensus report from the Food Allergy Research & Education (FARE) 2019 Oral Immunotherapy for Food Allergy Summit","volume":"146","author":"Pepper","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.06.038_bib34","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.alit.2018.02.006","article-title":"Nationwide questionnaire-based survey of oral immunotherapy in Japan","volume":"67","author":"Sato","year":"2018","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2023.06.038_bib35","first-page":"68","article-title":"The oral food desensitization in the Italian allergy centres","volume":"47","author":"Meglio","year":"2015","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.06.038_bib36","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/all.15016","article-title":"Food immunotherapy practice: nation differences across Europe, the FIND project","volume":"77","author":"Rodr\u00edguez Del R\u00edo","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.06.038_bib37","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1016\/j.jaip.2019.04.010","article-title":"First real-world safety analysis of preschool peanut oral immunotherapy","volume":"7","author":"Soller","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.06.038_bib38","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.anai.2020.06.044","article-title":"A\u00a0counseling video with pre- and posttesting and checklist for oral immunotherapy consent improves participant knowledge","volume":"125","author":"Mack","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.06.038_bib39","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.anai.2019.02.011","article-title":"An update on the controversy around offering oral immunotherapy to peanut-allergic children outside of research","volume":"122","author":"Soller","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.06.038_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2022.100687","article-title":"Managing food allergy: GA(2)LEN guideline 2022","volume":"15","author":"Muraro","year":"2022","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2023.06.038_bib41","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/all.13319","article-title":"EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy","volume":"73","author":"Pajno","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.06.038_bib42","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13223-020-0413-7","article-title":"CSACI guidelines for the ethical, evidence-based and patient-oriented clinical practice of oral immunotherapy in IgE-mediated food allergy","volume":"16","author":"B\u00e9gin","year":"2020","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2023.06.038_bib43","doi-asserted-by":"crossref","first-page":"225","DOI":"10.18176\/jiaci.0177","volume":"27","author":"Martorell","year":"2017","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2023.06.038_bib44","doi-asserted-by":"crossref","first-page":"279","DOI":"10.18176\/jiaci.0178","article-title":"Oral immunotherapy for food allergy: a Spanish Guideline. Egg and milk immunotherapy Spanish guide (ITEMS guide). Part II: maintenance phase of cow milk (CM) and egg oral immunotherapy (OIT), special treatment dosing schedules. models of dosing schedules","volume":"27","author":"Martorell","year":"2017","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2023.06.038_bib45","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1111\/all.15211","article-title":"Allergen immunotherapy and\/or biologicals for IgE-mediated food allergy: a systematic review and meta-analysis","volume":"77","author":"de Silva","year":"2022","journal-title":"Allergy Eur J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.06.038_bib46","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jaci.2022.02.032","article-title":"Clarifying the categorization of anaphylaxis as an adverse event during oral immunotherapy","volume":"150","author":"Turner","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.06.038_bib47","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/jama.2019.1113","article-title":"Effect of epicutaneous immunotherapy vs placebo on reaction to peanut protein ingestion among children with peanut allergy: the PEPITES randomized clinical trial","volume":"321","author":"Fleischer","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2023.06.038_bib48","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1056\/NEJMoa2212895","article-title":"Phase 3 trial of epicutaneous immunotherapy in toddlers with peanut allergy","volume":"388","author":"Greenhawt","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.06.038_bib49","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaci.2014.11.034","article-title":"Administration of a probiotic with peanut oral immunotherapy: a randomized trial","volume":"135","author":"Tang","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.06.038_bib50","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S2352-4642(17)30041-X","article-title":"Long-term clinical and immunological effects of probiotic and peanut oral immunotherapy after treatment cessation: 4-year follow-up of a randomised, double-blind, placebo-controlled trial","volume":"1","author":"Hsiao","year":"2017","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.jaip.2023.06.038_bib51","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S2352-4642(22)00006-2","article-title":"Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial","volume":"6","author":"Loke","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.jaip.2023.06.038_bib52","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/cea.14244","article-title":"Current and future treatments for peanut allergy","volume":"53","author":"Lee","year":"2023","journal-title":"Clin Exp allergy"},{"key":"10.1016\/j.jaip.2023.06.038_bib53","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.iac.2019.09.004","article-title":"Food allergy immunotherapy with adjuvants","volume":"40","author":"Nicolaides","year":"2020","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2023.06.038_bib54","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/pai.12767","article-title":"Combining anti-IgE with oral immunotherapy","volume":"28","author":"Lin","year":"2017","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2023.06.038_bib55","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/cea.13897","article-title":"The use of biologics in food allergy","volume":"51","author":"Fiocchi","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2023.06.038_bib56","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11882-020-0897-8","article-title":"New developments in non-allergen-specific therapy for the treatment of food allergy","volume":"20","author":"Long","year":"2020","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2023.06.038_bib57","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1016\/j.jaip.2022.05.015","article-title":"Peanut Oral Immunotherapy With or Without H1 and H2 Antihistamine Premedication for Peanut Allergy (PISCES): a placebo-controlled randomized clinical trial","volume":"10","author":"Chu","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.06.038_bib58","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11882-020-00973-x","article-title":"Oral immunotherapy for food allergy\u2014a US regulatory perspective","volume":"20","author":"Hise","year":"2020","journal-title":"Curr Allergy Asthma Rep"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823007055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823007055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T08:08:17Z","timestamp":1734422897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219823007055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2213219823007055"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2023.06.038","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Food Immunotherapy: Dissecting Current Guidelines and Navigating the Gray Zone","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2023.06.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}